Juan Gomez-Rivadeneira

Juan Gomez-Rivadeneira

University of New Hampshire
McNair Scholar, 2018
Major: Neuroscience and Behavior 
Mentor: Dr. Aruturo Andrade, Department of Biological Sciences 
Research Title: Dissecting Cell-Specific Roles Of α2δ-Proteins In Seizure-Like Activity Of Drosophilia Melanogaster (fruit fly)

Abstract:
Lyrica and Gabapentin are anticonvulsant medications that interact with α2δ-proteins to treat seizure-like activity. The α2δ-protein subunits of voltage gated calcium channels are extracellular and dynamically aid in synaptic transmission. The need to understand the cell specific expression patterns of α2δ-proteins may indicate a mechanistic function that links α2δ- protein dysfunction to seizure-like behavior. The two conserved α2δ-proteins of D. melanogaster (fruit fly), CG42817 and CG4587, will be used to investigate whether a2d protein disruption induces seizure-like behavior. Understanding the cell-specific role of α2δ-proteins can provide insights on increasing the specificity of anticonvulsant drugs used to treat epilepsy. A bioinformatic analysis quantifying gene expression done by the Allen Institute for Brain Science© (2004) indicated a cell-specific expression of α2δ genes within inhibitory and excitatory cell populations. The relevance of this cell-specific expression is currently unknown but understanding the cell-specific role of α2δ-proteins can provide insights for the creation of drugs that better target seizure-like symptoms. To assess the function of α2δ-proteins in the fruit fly, we will knock down expression of the CG42817 and CG4587 α2δ proteins within excitatory and inhibitory cell-specific populations. Transgenic fly lines expressing knocked down α2δ-gene expression will be used to evaluate seizure-like behavior. Using the behavior elicited from flies with knocked down α2δ expression, we hope to answer whether either CG gene is sufficient to impair seizure-like activity in the fruit fly. If either CG gene is associated with seizure like behavior, this will reveal a2d proteins as effective targets for medications used to treat epilepsies.

View 2018 McNair Scholars